Publications by authors named "T Hye"

Article Synopsis
  • Pulmonary arterial hypertension (PAH) is a rare condition characterized by high mean pulmonary arterial pressure due to abnormal cellular signaling in the pulmonary arteries, requiring targeted treatments.
  • Current PAH medications focus mainly on vasodilatory pathways, but emerging biologics, including monoclonal antibodies and recombinant proteins, show potential in addressing imbalances in critical signaling pathways like BMPRII and TGF-β.
  • Biologics, such as sotatercept, have demonstrated effectiveness in improving PAH symptoms and may offer a safer alternative to small molecule drugs, although they can cause immunogenic side effects.
View Article and Find Full Text PDF

Introduction: Drugs delivered via the lungs are predominantly used to treat various respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory tract infections and lung cancers, and pulmonary vascular diseases such as pulmonary hypertension. To treat respiratory diseases, targeted, modified or controlled release inhalation formulations are desirable for improved patient compliance and superior therapeutic outcome.

Areas Covered: This review summarizes the important factors that have an impact on the inhalable modified release formulation approaches with a focus toward various formulation strategies, including dissolution rate-controlled systems, drug complexes, site-specific delivery, drug-polymer conjugates, and drug-polymer matrix systems, lipid matrix particles, nanosystems, and formulations that can bypass clearance via mucociliary system and alveolar macrophages.

View Article and Find Full Text PDF

Background: Emotional eating has emerged as a contributing factor to overeating, potentially leading to obesity or disordered eating behaviors. However, the underlying biological mechanisms related to emotional eating remain unclear. The present study examined emotional, hormonal, and neural alterations elicited by an acute laboratory stressor in individuals with and without emotional eating.

View Article and Find Full Text PDF

Background: Obesity has one of the highest refractory rates of all chronic diseases, in part because weight loss induced by calorie restriction, the first-line treatment for obesity, elicits biological adaptations that promote weight regain. Although acute feeding trials suggest a role for macronutrient composition in modifying brain activity related to hunger and satiety, relevance of these findings to weight-loss maintenance has not been studied.

Objectives: We investigated effects of weight-loss maintenance diets varying in macronutrient content on regional cerebral blood flow (rCBF) in brain regions involved in hunger and reward.

View Article and Find Full Text PDF

Pulmonary arterial hypertension (PAH) affects more women than men, although affected females tend to survive longer than affected males. This sex disparity in PAH is postulated to stem from the diverse roles of sex hormones in disease etiology. In animal models, estrogens appear to be implicated not only in pathologic remodeling of pulmonary arteries, but also in protection against right ventricular (RV) hypertrophy.

View Article and Find Full Text PDF